The Lancet Infectious Diseases in conversation with
The Lancet Group

Ultimo episodio
127 episodi
Brecht Ingelbeen and Daniel Valia on a community-based antimicrobial stewardship intervention in Burkina Faso and DRC
15/06/2026 | 26 minDr Brecht Ingelbeen and Dr Daniel Valia join Senior Editor Phoebe Hall to discuss a new trial in the journal (the CABU-EICO trial) testing a co-created behavioural intervention bundle to improve antibiotic use, patient management, and water, sanitation and hygiene in rural communities in Burkina Faso and DR Congo.
They explain why the study focused on community prescribing (not hospitals), the primary endpoint was a reduction in WHO AWaRE Watch antibiotics (not overall antibiotics), and the intervention targeted all providers of antibiotics in the community, including informal vendors.
Finally, they discuss the importance of designing an intervention bundle that was truly tailored to local context yet practical, sustainable, and scalable beyond the study sites. A parallel study reporting the effect of the intervention bundle on ESBL-producing Escherichia coli colonisation (a co-primary outcome of the trial) is in press at The Lancet Microbe.
To read the full article:
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00169-6/fulltext
The Lancet Infectious Diseases in conversation with... is part of the Lancet Group podcast offering.
Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall
Podcast editing: Matteo Simonetti
Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering.
Find the best science for better lives at lancet.com
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettvSara Tartof and Matan Yechezkel on durability of doxycycline effectiveness against syphilis, gonorrhoea, and chlamydia after implementation of post-exposure prophylaxis in southern California
07/05/2026 | 25 minSara Tartof and Matan Yechezkel discuss a new article in The Lancet Infectious Diseases about emerging doxycycline resistance against gonorrhoea and its wider implications for the implementation of doxycycline and the prevention of bacterial sexually transmitted infections.
Click here to read the full article:
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00123-4/fulltext
The Lancet Infectious Diseases in conversation with... is part of the Lancet Group podcast offering.
Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall
Podcast editing: Matteo Simonetti
Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering.
Find the best science for better lives at lancet.com
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv- Dr Jenny Clarke and Herve Semukunzi discuss a study they and colleagues recently published with us titled ‘Infection- and vaccine-induced mpox antibodies: validation of a combined mpox IgG ELISA during the clade 1b outbreak in Rwanda’.
They also discuss the reasons for the paucity of validated serological assays for mpox, particularly in outbreak regions where they are most urgently needed.
Click here to read the full article:
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00006-X/fulltext
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
The Lancet Infectious Diseases in conversation with... is part of the Lancet Group podcast offering.
Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall
Podcast editing: Matteo Simonetti
Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering.
Find the best science for better lives at lancet.com
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv - Dr Julia Moore Vogel and Dr Danilo Buonsenso discuss various aspects of long COVID including epidemiology, pathophysiology, underlying mechanisms, management, latest research developments, difficulties in conducting clinical trials, and future research priorities.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
The Lancet Infectious Diseases in conversation with... is part of the Lancet Group podcast offering.
Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall
Podcast editing: Matteo Simonetti
Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering.
Find the best science for better lives at lancet.com
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv - Professors Steven Tong and Joshua Davis discuss all aspects of adaptive platform trials including advantages, disadvantages, differences from conventional trials, and tips for setting up and assessing them.
They also highlight several adaptive platform trials currently in the pipeline that could influence infectious disease clinical practise in the future.
Click here to read our latest issue
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
The Lancet Infectious Diseases in conversation with... is part of the Lancet Group podcast offering.
Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall
Podcast editing: Matteo Simonetti
Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering.
Find the best science for better lives at lancet.com
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Altri podcast di Medicina
Podcast di tendenza in Medicina
Su The Lancet Infectious Diseases in conversation with
The editorial team of The Lancet Infectious Diseases, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy. An audio companion to the journal, this podcast covers a broad range of topics, from mpox diagnostics in Africa, long COVID, adaptive trials in infectious diseases, tuberculosis drug development, and more.
Sito web del podcastAscolta The Lancet Infectious Diseases in conversation with, The Peter Attia Drive e molti altri podcast da tutto il mondo con l’applicazione di radio.it

Scarica l'app gratuita radio.it
- Salva le radio e i podcast favoriti
- Streaming via Wi-Fi o Bluetooth
- Supporta Carplay & Android Auto
- Molte altre funzioni dell'app
Scarica l'app gratuita radio.it
- Salva le radio e i podcast favoriti
- Streaming via Wi-Fi o Bluetooth
- Supporta Carplay & Android Auto
- Molte altre funzioni dell'app


The Lancet Infectious Diseases in conversation with
Scansione il codice,
scarica l'app,
ascolta.
scarica l'app,
ascolta.
The Lancet Infectious Diseases in conversation with: Podcast correlati












